Proventa provides an environment for pharma and biotechs to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join us in along with a host of drug discovery professionals from across Europe, to discover:
Please register for free here or use VIP code: BB-VIP-2022.
Meet Kam Dhaliwal, Senior VP Business Development & Alliance Management to discuss how bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant, phenotypically characterised, offering predictive, in vitro, human cells for drug screening, toxicity testing, regenerative medicine, and tissue engineering applications.
Despite cell culture models being used for over 120 years to study human health and disease issues such as accuracy and reproducibility present significant hurdles for in vitro testing. Join our round table at 11:10am-12:10pm 'Addressing the current challenges of in vitro cell models and their translation into the clinic’. The roundtable discussion will focus on the main challenges associated with in vitro human cell models as a platform for disease modelling and drug discovery, addressing issues such as:
Click on the button below to arrange a meeting with Kam.